{"schema_version":"secwatch.filing_event.v1","accession":"0001040130-25-000012","form_type":"8-K","ticker":"PETS","cik":"0001040130","company_name":"PETMED EXPRESS INC","filed_at":"2025-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.770189+00:00","generated_at":"2026-05-26T23:46:40.829042+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"PetMed Express Q3 net sales $53M; Adj. EBITDA rises to $2M from $0.9M","bullets":["Net sales of $53.0 million in Q3 fiscal 2025.","Gross margin rate 28.1%, up 80 bps from prior year.","Adjusted EBITDA $2.0 million vs. $0.9 million prior year, a $1.1M improvement.","G&A expenses reduced by $2.6 million year-over-year.","CEO highlights transformation progress and operational efficiency."],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-25-000012","json":"https://secwatch.observer/filing/0001040130-25-000012.json","markdown":"https://secwatch.observer/filing/0001040130-25-000012.md","text":"https://secwatch.observer/filing/0001040130-25-000012.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013025000012/0001040130-25-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013025000012/pets-20250210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T23:46:40.829042+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}